Vera Therapeutics
Filed with the SEC on · accession 0001193125-26-449780
VERA filed a 8-K (current report) with the SEC on Nov 5, 2026. A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The stock moved -5.7% by the first close after the filing.
Vera Therapeutics filed a routine Form 8-K cover page with no substantive corporate event disclosed.
Close before
$31.97
Nov 4, 2026
First close after
-5.72%
$30.14
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for VERA, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for VERA?
Click hereVERA filed a 8-K (SEC filing). Vera Therapeutics filed a routine Form 8-K cover page with no substantive corporate event disclosed.
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
VERA closed at $31.97 before the filing and $30.14 on Nov 5, 2026 (-5.72%).
Get alerts when VERA files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days